Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2004-03, Vol.18 (5), p.821-823
Hauptverfasser:	GIANOTTI, Nicola, SORIA, Alessandro, GALLI, Laura, GIUDICI, Barbara, FUSETTIA, Giuliana, LAZZARIN, Adriano, BTEERI, Enzo, CASTAGNA, Antonella
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS/HIV Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral Therapy, Highly Active Antiviral agents Biological and medical sciences CD4 Lymphocyte Count Drug Administration Schedule Drug Resistance, Multiple, Viral HIV Infections - drug therapy HIV Infections - immunology HIV Protease Inhibitors - administration & dosage HIV Protease Inhibitors - therapeutic use HIV-1 Human viral diseases Humans Infectious diseases Linear Models Medical sciences Pharmacology. Drug treatments Treatment Outcome Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!